Buchumschlag

PD-1/PD-L1 pathway in breast cancer

The programmed cell death-1 receptor (PD-1) is an immune checkpoint inhibitor which is expressed on the surface of immune effector cells. It is activated mainly by PD-L1 which can be expressed by all human cells. The PD-1/PD-L1 pathway plays a subtle role in maintaining peripheral T-lymphocyte toler...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schütz, Florian (VerfasserIn) , Stefanovic, Stefan (VerfasserIn) , Mayer, Luisa (VerfasserIn) , Au, Alexandra von (VerfasserIn) , Domschke, Christoph (VerfasserIn) , Sohn, Christof (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 27, 2017
In: Oncology research and treatment
Year: 2017, Jahrgang: 40, Heft: 5, Pages: 294-297
ISSN:2296-5262
DOI:10.1159/000464353
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1159/000464353
Verlag, Volltext: https://www.karger.com/Article/FullText/464353
Volltext
Verfasserangaben:Florian Schütz, Stefan Stefanovic, Luisa Mayer, Alexandra von Au, Christoph Domschke, Christof Sohn

MARC

LEADER 00000caa a2200000 c 4500
001 1572223235
003 DE-627
005 20220814121329.0
007 cr uuu---uuuuu
008 180420s2017 xx |||||o 00| ||eng c
024 7 |a 10.1159/000464353  |2 doi 
035 |a (DE-627)1572223235 
035 |a (DE-576)502223235 
035 |a (DE-599)BSZ502223235 
035 |a (OCoLC)1341007347 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schütz, Florian  |d 1972-  |e VerfasserIn  |0 (DE-588)12303387X  |0 (DE-627)082307229  |0 (DE-576)293528810  |4 aut 
245 1 0 |a PD-1/PD-L1 pathway in breast cancer  |c Florian Schütz, Stefan Stefanovic, Luisa Mayer, Alexandra von Au, Christoph Domschke, Christof Sohn 
264 1 |c March 27, 2017 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.04.2018 
520 |a The programmed cell death-1 receptor (PD-1) is an immune checkpoint inhibitor which is expressed on the surface of immune effector cells. It is activated mainly by PD-L1 which can be expressed by all human cells. The PD-1/PD-L1 pathway plays a subtle role in maintaining peripheral T-lymphocyte tolerance and regulating inflammation. In cancer, the expression of PD-L1 seems to be one of the major immune escape mechanisms. Many studies have shown efficacy of blocking PD-1 or PD-L1 with specific antibodies like pembrolizumab or atezulizumab. In breast cancer, potential response was demonstrated in metastatic triple-negative breast cancers. 
700 1 |a Stefanovic, Stefan  |e VerfasserIn  |0 (DE-588)111256117X  |0 (DE-627)866525831  |0 (DE-576)476625564  |4 aut 
700 1 |a Mayer, Luisa  |e VerfasserIn  |0 (DE-588)1037466713  |0 (DE-627)755790472  |0 (DE-576)391498541  |4 aut 
700 1 |a Au, Alexandra von  |d 1985-  |e VerfasserIn  |0 (DE-588)1022333909  |0 (DE-627)716953366  |0 (DE-576)362850666  |4 aut 
700 1 |a Domschke, Christoph  |d 1982-  |e VerfasserIn  |0 (DE-588)139103201  |0 (DE-627)703207679  |0 (DE-576)310245095  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
773 0 8 |i Enthalten in  |t Oncology research and treatment  |d Basel : Karger, 2014  |g 40(2017), 5, Seite 294-297  |h Online-Ressource  |w (DE-627)776629611  |w (DE-600)2749752-5  |w (DE-576)400081660  |x 2296-5262  |7 nnas  |a PD-1/PD-L1 pathway in breast cancer 
773 1 8 |g volume:40  |g year:2017  |g number:5  |g pages:294-297  |g extent:4  |a PD-1/PD-L1 pathway in breast cancer 
856 4 0 |u http://dx.doi.org/10.1159/000464353  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.karger.com/Article/FullText/464353  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180420 
993 |a Article 
994 |a 2017 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 6  |y j 
998 |g 139103201  |a Domschke, Christoph  |m 139103201:Domschke, Christoph  |d 910000  |d 910400  |e 910000PD139103201  |e 910400PD139103201  |k 0/910000/  |k 1/910000/910400/  |p 5 
998 |g 1022333909  |a Au, Alexandra von  |m 1022333909:Au, Alexandra von  |d 910000  |d 910400  |e 910000PA1022333909  |e 910400PA1022333909  |k 0/910000/  |k 1/910000/910400/  |p 4 
998 |g 1037466713  |a Mayer, Luisa  |m 1037466713:Mayer, Luisa  |d 910000  |d 910400  |e 910000PM1037466713  |e 910400PM1037466713  |k 0/910000/  |k 1/910000/910400/  |p 3 
998 |g 111256117X  |a Stefanovic, Stefan  |m 111256117X:Stefanovic, Stefan  |d 910000  |d 910400  |e 910000PS111256117X  |e 910400PS111256117X  |k 0/910000/  |k 1/910000/910400/  |p 2 
998 |g 12303387X  |a Schütz, Florian  |m 12303387X:Schütz, Florian  |d 910000  |d 910400  |d 50000  |e 910000PS12303387X  |e 910400PS12303387X  |e 50000PS12303387X  |k 0/910000/  |k 1/910000/910400/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1572223235  |e 3006551354 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 20.04.2018"],"recId":"1572223235","person":[{"role":"aut","family":"Schütz","display":"Schütz, Florian","given":"Florian"},{"given":"Stefan","display":"Stefanovic, Stefan","family":"Stefanovic","role":"aut"},{"display":"Mayer, Luisa","given":"Luisa","role":"aut","family":"Mayer"},{"family":"Au","role":"aut","display":"Au, Alexandra von","given":"Alexandra von"},{"display":"Domschke, Christoph","given":"Christoph","role":"aut","family":"Domschke"},{"display":"Sohn, Christof","given":"Christof","role":"aut","family":"Sohn"}],"language":["eng"],"name":{"displayForm":["Florian Schütz, Stefan Stefanovic, Luisa Mayer, Alexandra von Au, Christoph Domschke, Christof Sohn"]},"origin":[{"dateIssuedDisp":"March 27, 2017","dateIssuedKey":"2017"}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"PD-1/PD-L1 pathway in breast cancerOncology research and treatment","pubHistory":["37.2014 -"],"note":["Gesehen am 15.12.2023"],"part":{"issue":"5","extent":"4","pages":"294-297","text":"40(2017), 5, Seite 294-297","year":"2017","volume":"40"},"language":["eng"],"origin":[{"dateIssuedKey":"2014","publisherPlace":"Basel","publisher":"Karger","dateIssuedDisp":"2014-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2749752-5"],"eki":["776629611"],"issn":["2296-5262"]},"title":[{"title":"Oncology research and treatment","title_sort":"Oncology research and treatment"}],"recId":"776629611"}],"id":{"eki":["1572223235"],"doi":["10.1159/000464353"]},"physDesc":[{"extent":"4 S."}],"title":[{"title":"PD-1/PD-L1 pathway in breast cancer","title_sort":"PD-1/PD-L1 pathway in breast cancer"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a SCHUETZFLOPD1PDL1PAT2720 

Ähnliche Einträge